KineMed (KNMD) Withdrawn

Develops biomarker tests that measure disease progression to improve commercial drugs.

Health Care -

IPO Performance
Latest Trade ()
First Day Return
Return from IPO
 
KineMed IPO News more
  • .
IPO Data
IPO File Date 01/08/2014
Offer Price
Price Range $6.50 - $7.50
Offer Shares (mm) 4.5
Deal Size ($mm) $32
 
IPO Data
IPO Date
Offer Price
Price Range $6.50 - $7.50
Offer Shares (mm) 4.5
Deal Size ($mm) $$32
 
Underwriters
more
Business Overview
Develops biomarker tests that measure disease progression to improve commercial drugs.
Develops biomarker tests that measure disease progression to improve commercial drugs.
more
Company Data
Headquarters Emeryville, CA
Founded 2001
Employees 49
Website www.kinemed.com
 

Performance vs. IPO Index (IPOUSA)